机构

• 上海药物研究所 [41]
• 深圳先进技术研究院 [11]
• 近代物理研究所 [3]
• 工程热物理研究所 [3]
• 生态环境研究中心 [2]
• 合肥物质科学研究院 [2]
• 更多

采集方式

• OAI收割 [67]

内容类型

• 期刊论文 [62]
• 会议论文 [5]

发表日期

• 2025 [1]
• 2024 [2]
• 2023 [6]
• 2022 [6]
• 2021 [7]
• 2020 [6]
• 更多

学科主题

筛选

浏览/检索结果: 共67条，第1-10条 帮助 条数/页： 5101520253035404550556065707580859095100 排序方式： 请选择题名升序题名降序提交时间升序提交时间降序作者升序作者降序发表日期升序发表日期降序 Exploratory research on the effective chemical basis of tanreqing injection for treating acute lung injury: In vivo, in vitro and in silico 期刊论文  OAI收割 JOURNAL OF ETHNOPHARMACOLOGY, 2025, 卷号: 337, 页码: 11 作者:  Tang, Bixi   |  收藏  |  浏览/下载：12/0  |  提交时间：2024/11/26 Lung first-pass effect  Tanreqing injection  Pharmacokinetics  Sepsis-associated acute lung injury  Acute respiratory distress syndrome   Dihydrocelastrol induces cell death and suppresses angiogenesis through BCR/AP-1/junb signalling in diffuse large B cell lymphoma 期刊论文  OAI收割 ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS, 2024, 卷号: 754, 页码: 11 作者:  Lai, Yue;  Guo, Shushan;  Tang, Qiongwei;  Chang, Gaomei;  Zhang, Hui   |  收藏  |  浏览/下载：21/0  |  提交时间：2024/05/07 Dihydrocelastrol  Angiogenesis  Apoptosis  Jun B  p65   A novel pterostilbene compound DCZ0825 induces macrophage M1 differentiation and Th1 polarization to exert anti-myeloma and immunomodulatory 期刊论文  OAI收割 INTERNATIONAL IMMUNOPHARMACOLOGY, 2024, 卷号: 127, 页码: 14 作者:  Zhang, Hui;  Hu, Ke;  Lu, Yumeng;  Xu, Zhijian;  Chen, Gege   |  收藏  |  浏览/下载：35/0  |  提交时间：2024/03/25 Multiple myeloma  M1 macrophages  Th1 cells  Immunomodulatory   Berberine derivative DCZ0358 induce oxidative damage by ROS-mediated JNK signaling in DLBCL cells 期刊论文  OAI收割 INTERNATIONAL IMMUNOPHARMACOLOGY, 2023, 卷号: 125, 页码: 15 作者:  Feng, Qilin;  Hu, Ke;  Hu, Huifang;  Lu, Yumeng;  Zhang, Hui   |  收藏  |  浏览/下载：52/0  |  提交时间：2024/01/16 DLBCL  ROS  DNA damage  JNK  Mitochondrial dysfunction   The novel norcantharidin derivative DCZ5417 suppresses multiple myeloma progression by targeting the TRIP13-MAPK-YWHAE signaling pathway 期刊论文  OAI收割 JOURNAL OF TRANSLATIONAL MEDICINE, 2023, 卷号: 21, 期号: 1, 页码: 17 作者:  Wang, Yingcong;  Dong, Sanfeng;  Hu, Ke;  Xu, Li;  Feng, Qilin   |  收藏  |  浏览/下载：39/0  |  提交时间：2024/01/26 Norcantharidin  Derivative  DCZ5417  TRIP13  Anti-myeloma  MAPK   Design, synthesis and biological evaluation of chalcone derivatives as potent and orally active hCYP3A4 inhibitors 期刊论文  OAI收割 BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2023, 卷号: 95, 页码: 9 作者:  Lu, Shiwei;  Zhang, Feng;  Gong, Jiahao;  Huang, Jian;  Zhu, Guanghao   |  收藏  |  浏览/下载：26/0  |  提交时间：2023/12/08 Cytochrome P450 3A4 (CYP3A4)  Inhibitors  Isoquinoline chalcones  Orally active   Molecular mechanism by which RRM2-inhibitor (cholagogue osalmid) plus bafilomycin A1 cause autophagic cell death in multiple myeloma 期刊论文  OAI收割 ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS, 2023, 卷号: 747, 页码: 12 作者:  Guo, Shushan;  Xu, Zhijian;  Feng, Qilin;  Zhang, Hui;  Yu, Dandan   |  收藏  |  浏览/下载：23/0  |  提交时间：2023/12/11 Autophagy  RRM2  p62  RIPK3  Cholagogue osalmid  Bafilomycin A1   Aberrant activation of TRIP13-EZH2 signaling axis promotes stemness and therapy resistance in multiple myeloma 期刊论文  OAI收割 LEUKEMIA, 2023, 页码: 4 作者:  Xu, Li;  Wang, Yingcong;  Wang, Guanli;  Guo, Shushan;  Yu, Dandan   |  收藏  |  浏览/下载：41/0  |  提交时间：2023/10/17 Preventive and therapeutic benefits of nelfinavir in rhesus macaques and human beings infected with SARS-CoV-2 期刊论文  OAI收割 Signal Transduction and Targeted Therapy, 2023, 卷号: 8, 期号: 5, 页码: 2384-2391 作者:  Xu, Zhijian;  Shi, Danrong;  Han, Jianbao;  Ling, Yun;  Jiang, Xiangrui   |  收藏  |  浏览/下载：39/0  |  提交时间：2024/03/27 DCZ19931, a novel multi-targeting kinase inhibitor, inhibits ocular neovascularization 期刊论文  OAI收割 SCIENTIFIC REPORTS, 2022, 卷号: 12, 期号: 1, 页码: 15 作者:  Zhang, Huiying;  Li, Bo;  Ding, Jingjuan;  Ye, Rong;  Xu, Zhijian   |  收藏  |  浏览/下载：34/0  |  提交时间：2023/10/17